Bellevue Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Bellevue Asset Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,433	Closed	-$13K	–	563
2021 Q4	$13K	Hold	1,433	–	–	0.01%	310
2021 Q3	$21K	Hold	1,433	–	–	0.01%	281
2021 Q2	$24K	Hold	1,433	–	–	0.01%	269
2021 Q1	$26K	Hold	1,433	–	–	0.02%	259
2020 Q4	$15K	Hold	1,433	–	–	0.01%	312
2020 Q3	$6K	Hold	1,433	–	–	﹤0.01%	373
2020 Q2	$6K	Hold	1,433	–	–	0.01%	376
2020 Q1	$5K	Hold	1,433	–	–	0.01%	394
2019 Q4	$7K	Buy	+1,433	New	+$9.08K	0.01%	337

Other funds holding ORGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bellevue Asset Management's ORGO Position: Q1 2022 in Review

Bellevue Asset Management sold out of Organogenesis Holdings (ORGO) in Q1 2022, closing a stake of 1,433 shares — an estimated $13K sold.

Bellevue Asset Management first reported a position in ORGO in Q4 2019 and held it in 9 quarters. The position peaked at $26K in Q1 2021. 156 funds tracked by Wall St. Rank hold ORGO as of Q1 2022.

Bellevue Asset Management reported no remaining Organogenesis Holdings position as of Q1 2022 after selling out during the quarter.
Bellevue Asset Management sold 1,433 Organogenesis Holdings shares in Q1 2022, an estimated $13K.
Bellevue Asset Management first reported a position in Organogenesis Holdings in Q4 2019 and held it in 9 quarters.
Bellevue Asset Management's Organogenesis Holdings position peaked at $26K in Q1 2021.
156 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2022.

Based on Bellevue Asset Management's 13F filing for Q1 2022, filed 11 May 2022.